Drug application
SEMAGLUTIDE (SEMAGLUTIDE)
Drugs@FDA ANDA 220314 · APOTEX INC
Key facts
| Drug name | SEMAGLUTIDE |
|---|---|
| Active ingredients | SEMAGLUTIDE |
| Application type | ANDA |
| Application number | 220314 |
| Company | APOTEX INC |
| Dosage forms | INJECTION, SOLUTION |
| Strength | 2MG/3ML |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission status date | Apr 7, 2026 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.